Clínica e Investigación en Arteriosclerosis

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clínica e Investigación en Arteriosclerosis is a journal published by Elsevier BV in Spain. It is listed in MEDLINE according to the sources read. Declared publication charge: 1,640 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1578-1879 · 0214-9168
Country
Spain
Access
Not open access / not declared
Declared publication charge
1,640 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2013-01-01
Indexing
MEDLINE
APC
1,640 USD
Declared review time (DOAJ)
—
Actual review time (measured)
54 days received→accepted — computed from PubMed (n=91)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1454

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

29

i10-index

121

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
97%
ORCID iDs in current deposits
45%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9208512
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Atherosclerosis and Cardiovascular Diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
Show all subjects (50)
  • Health and Lifestyle Studies
  • Health and Lifestyle Studies
  • Blood Pressure and Hypertension Studies
  • Blood Pressure and Hypertension Studies
  • Cholesterol and Lipid Metabolism
  • Cholesterol and Lipid Metabolism
  • Lipid metabolism and disorders
  • Lipid metabolism and disorders
  • Peroxisome Proliferator-Activated Receptors
  • Peroxisome Proliferator-Activated Receptors
  • Adipose Tissue and Metabolism
  • Adipose Tissue and Metabolism
  • Nutritional Studies and Diet
  • Nutritional Studies and Diet
  • Cardiac Health and Mental Health
  • Cardiac Health and Mental Health
  • Diet and metabolism studies
  • Cardiovascular Function and Risk Factors
  • Diet and metabolism studies
  • Cardiovascular Function and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Disease and Adiposity
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Health and Disease Prevention
  • Cardiovascular Health and Disease Prevention
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Diet, Metabolism, and Disease
  • Cerebrovascular and Carotid Artery Diseases
  • Cerebrovascular and Carotid Artery Diseases
  • Diet, Metabolism, and Disease
  • Pharmacology and Obesity Treatment
  • Pharmacology and Obesity Treatment
  • Obesity, Physical Activity, Diet
  • Obesity, Physical Activity, Diet
  • Diabetes and associated disorders
  • HIV-related health complications and treatments
  • Diabetes and associated disorders
  • HIV-related health complications and treatments

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: